G-Rex® bioreactors incubated in Heracell™ Vios™ CR CO₂ Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

Overview
This article details how closed-system G-Rex® bioreactors, specifically the G-Rex® 500M-CS, paired with Heracell Vios incubators, prevent contamination in cell therapy production. It confirms G-Rex® sterile fluid path integrity via microbial ingress and viral penetration testing.
What this paper found
Closed-system G-Rex® bioreactors held in Vios iDx CR CO2 incubators showed no bacterial ingress and no viral penetration, supporting contamination-controlled parallel cell therapy manufacturing. In a 14-day full-immersion bacterial challenge, all three test bioreactors showed no growth. All 32 membrane samples passed bacteriophage Phi-X174 penetration testing, with an assay titer below 1 PFU/mL. With ten filled G-Rex® 500M-CS in the chamber, temperature recovered in 5.3 minutes and CO2 in 5.0 minutes after a 60-second door opening. The CultiMaxx shelving kept temperature uniformity within ±0.3 °C, and in-chamber HEPA filtration reached ISO Class 5 in about 5 minutes. Stacked incubators could yield a projected 400 billion cells in just over 3 square feet.
Note: The cell yields cited are projections from reported per-vessel capacity; the tests described are equipment and device tests, not cell cultures.
These test results support closed-system G-Rex bioreactors in cell therapy and GMCT manufacturing processes in low-cost and lower-grade cleanrooms. — Mary Kay Bates, Dan Fick, Jürgen Schneider, Dan Welch, Josh Ludwig, Cell and Gene Therapy Insights
Study details
- Authors
- Mary Kay Bates, Dan Fick, Jürgen Schneider, Dan Welch, Josh Ludwig
- Institution
- Thermo Fisher Scientific, Waltham, MA, USA · Wilson Wolf Manufacturing LLC, St Paul, MN, USA · ScaleReady USA LLC, St Paul, MN, USA
- Journal
- Cell and Gene Therapy Insights
- Year
- 2024
- G-Rex® model(s)
- G-Rex®500M-CS
- Cell type(s)
- CAR T Cells, NK Cells, T-Cells
- Application area
- Other
- Study phase
- Preclinical
How G-Rex® was used
Ten G-Rex® 500M-CS bioreactors, each filled with 5 L of water pre-heated to 37 °C, were loaded into a Vios iDx CR CO2 incubator on CultiMaxx shelving to test temperature, CO2 and humidity recovery after a 60-second opening of both doors. For the microbial ingress test, test bioreactors were filled with 5,000 mL of Nutrient Broth Media, weighted and fully immersed in 12 L of bacterial challenge solution for 14 days; all three showed no growth. In a separate test, 32 samples of G-Rex® membrane material showed no bacteriophage penetration.
Explore related
Full citation
Bates MK, Fick D, Schneider J, Welch D, Ludwig J. G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production. Cell Gene Therapy Insights. 2024;10(04):593-607.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.